Kalaris Therapeutics Inc (KLRS)

$8.07 +0.07 (0.87%)
Market Cap 40.35M
Revenue (ttm) 0.00
Net Income (ttm) -58.77M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 14,000
Avg Vol 21,832
Day's Range N/A - N/A
Shares Out 5.04M
Stochastic %K 5%
Beta 0.68
Analysts Strong Buy
Price Target N/A

Latest News on KLRS

Kalaris Announces Closing of Merger with AlloVir

Mar 18, 2025, 4:21 PM EDT - 15 days ago

Kalaris Announces Closing of Merger with AlloVir

ALVR